Regulus Therapeutics Inc. (RGLS) said Tuesday that it has named Stelios Papadopoulos Chairman of its Board of Directors, effective immediately.
Dr. Papadopoulos assumes the role of Chairman of the Board from John Maraganore, who will remain a member of the board.
Dr. Papadopoulos, who has been a member of the Regulus board since 2008, has more than 30 years of experience in the biotechnology and pharmaceutical industries as an investment banker, board member, company founder and investor. He is a Board member of several companies including Biogen Idec, Inc. and Exelixis, Inc., where he is Chairman.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.